Summary
                        
        
                            Includes requirements of regulatory authorities and ethics committees for approval of IRPs informed consent protocol amendments openingclosing of arms and issues in assessment of IRPs for regulatory approval of new medicinal products by regulatory authorities eg European National Authorities EMA and FDA and assessment by HTAs
                    
    
        
                                 
                    More information & hyperlinks
                        
         
                             
                             
                            